Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets - The BioCentury Show

Om avsnittet

On This Edition of The BioCentury Show, Gonçalo Abecasis, SVP and Chief Genomics and Data Sciences Officer at the Regeneron Genetics Center, joins BioCentury’s Tierney Baum to discuss genetics as a scalable drug discovery platform and the practical use of AI in genomics.

View full story: https://www.biocentury.com/article/660697

#Genomics #DrugDiscovery #AI #GeneticMedicines #ClinicalTrials

0:00 - Introduction
1:14 - Regeneron Genetics Center
10:29 - Acting on Genetic Signals
16:57 - Getting to Drug Development
21:51 - Best AI Use Cases

Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets

Om avsnittet

Fler avsnitt

Ep. 120 - Canaan’s Julie Grant on building biotechs in white spaces

Ep. 119 - Blackstone's Galakatos on funding biotech's hardest mile

Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient

Ep. 116 - Ovid's Jeremy Levin on biotech in the balance

Ep. 115 - Initiate's Owens on what it takes to be AI-native

Ep. 114 - Roivant’s Matt Gline on commercial launches and the future of the vant model

Ep. 113 - Frank Jiang on Hengrui’s rise and China’s new era of biopharma dealmaking

Ep. 112 - Chris Arendt on rebuilding Takeda for AI

Ep. 111 - McGill's Angela Genge on why ALS drug development is turning a corner

Ep. 110 - Richard Pops on Three Decades in Biotech: Drug pricing, FDA and China